Arkolith/Insider Trading/CORT/Form 4

Mokari Atabak

Chief Financial OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.2M
Net Open-Market Flow
-$3.2M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)40K$19.26$770K56K
Jun 15, 2026Sell(S)9K$80.02$755K47K
Jun 15, 2026Sell(S)11K$80.94$897K36K
Jun 15, 2026Sell(S)19K$81.81$1.6M16K
Jun 15, 2026Sell(S)2$82.45$16516K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 15, 2026Option exercise(M)40K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-274224) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML